High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure
Non-randomised trial
OA: closed
CC0
⤵ 10 in-corpus citations
AI-generated summary
This study investigated the efficacy of high-dose, short-term glucocorticoid treatment in addressing infertility caused by premature ovarian failure.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate prospectively the effects of high-dose, short-term treatment with a glucocorticoid in an attempt to normalize ovarian failure and induce pregnancy in women presenting with infertility.
DESIGN: Uncontrolled, nonrandomized prospective study.
SETTING: Two university-based reproductive endocrinology clinics.
PATIENTS: Eleven consecutive women with premature ovarian failure (POF) who were desirous of pregnancy.
INTERVENTIONS: Prednisone 25 mg four times per day for 2 weeks.
MAIN OUTCOME MEASURES: Two women demonstrated normalization of their serum gonadotropins, an increase of serum E2, and ultrasonographic visualization of follicular growth, with both conceiving. The other nine demonstrated no biochemical or clinical response.
CONCLUSIONS: Premature ovarian failure may not be an irreversible process and may either spontaneously resolve or may respond to therapeutic modalities such as high-dose glucocorticoids in selected patients. In this uncontrolled study, the results were best with women with concomitant autoimmune thyroid disease and POF of < 2 years' duration.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (22)
- Premature ovarian failure: clinical presentation and treatment via openalex
- doi:10.1016/0002-9378(82)90402-1 via openalex
- doi:10.1016/0002-9343(86)90277-9 via openalex
- doi:10.1136/bmj.281.6253.1447 via openalex
- doi:10.1016/s0015-0282(16)48266-x via openalex
- doi:10.1097/00006250-198603001-00018 via openalex
- doi:10.1210/jcem-70-1-69 via openalex
- doi:10.1097/00006254-198703000-00020 via openalex
- doi:10.1016/s0015-0282(16)45687-6 via openalex
- W2410493765 via openalex
- doi:10.1016/0002-9378(88)90791-0 via openalex
- doi:10.1016/s0015-0282(16)46768-3 via openalex
- doi:10.1210/jcem-73-2-360 via openalex
- doi:10.1097/00006254-198742030-00020 via openalex
- W2472208855 via openalex
- W6607327656 via openalex
- W6714228507 via openalex
- doi:10.1210/jcem-54-6-1221 via openalex
- doi:10.1016/s0015-0282(16)60785-9 via openalex
- doi:10.1210/jcem-64-3-494 via openalex
- doi:10.1201/9780203021941-28 via openalex
- doi:10.1093/ajcp/81.1.105 via openalex
Cited by (7)
- The ovarian immune pathology and reproductive failures 2022
- An investigational ovarian stimulation protocol increased significantly the psychological burden in women with premature ovarian failure 2012
- Ovarian failure and polycystic ovary syndrome 2011
- An immunological insight into premature ovarian failure (POF) 2010
- Chapter 14 Autoantibodies and Infertility in Autoimmune Diseases 2008
- Autoimmunity and antigenic targets in ovarian pathology 2004
- A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure 1994
Source provenance
- openalex
- last seen: 2026-05-13T18:43:51.602584+00:00
- pubmed
- last seen: 2026-10-08T21:59:37.277143+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK